Latest Earnings Analysis

• Global-e (GLBE) Q2 2025: GMV Jumps 34% as Tariff Complexity Drives Merchant Demand
  August 13, 2025 · GLBE
• European Wax Center (EWCZ) Q2 2025: Adjusted EBITDA Margin Climbs 420bps as Turnaround Initiatives Gain Traction
  August 13, 2025 · EWCZ
• SBC (SBC) Q2 2025: Clinic Count Up 36 as Strategic Restructuring Sets Stage for Margin Recovery
  August 13, 2025 · SBC
• BrainsWay (BWAY) Q2 2025: $62M Backlog Anchors Multi-Year Lease Expansion
  August 13, 2025 · BWAY
• PolyPid (PYPD) Q2 2025: DPLEX-100 Cuts Surgical Infection Rates by 58%, Unlocking U.S. Partner Leverage
  August 13, 2025 · PYPD
• NOVA (CAAS) Q2 2025: Gross Margin Hits 60% on Advanced Packaging and Gate-All-Around Tailwinds
  August 13, 2025 · CAAS
• Tiendas 3B (TBBB) Q2 2025: 142 New Stores Drive 38% Sales Surge, Margin Tradeoff Deepens
  August 13, 2025 · TBBB
• Vinci Partners (VINP) Q2 2025: Fee-Related Revenue Surges 85% as Credit and Alternatives Drive Multi-Strategy Momentum
  August 13, 2025 · VINP
• Consumer Portfolio Services (CPSS) Q2 2025: Originations Hit $433M as Cost Discipline Lowers OpEx to Decade Low
  August 13, 2025 · CPSS
• EVE Air Mobility (SPNS) Q2 2025: $14B Backlog Anchors 2027 Service Entry, Prototype Flight Nears
  August 13, 2025 · SPNS
• IDN Q2 2025: Banking Revenue Up 85% YoY Offsets Retail Decline, Channel Strategy Expands Reach
  August 13, 2025 · IDN
• ANTA (ANTA) Q2 2025: Margin Loan TVL Jumps 50% as Collateral Innovation Expands TAM
  August 13, 2025 · ANTA
• Marchex (MCHX) Q2 2025: Engage Platform Drives Sequential ACV Growth as Migration Nears Completion
  August 13, 2025 · MCHX
• Prairie Operating (PROP) Q2 2025: Production Surges 540% as M&A and Cost Discipline Reshape Trajectory
  August 13, 2025 · PROP
• Double Down Interactive (DDI) Q2 2025: SuperNation iGaming Revenue Doubles, Fueling Diversification Push
  August 13, 2025 · DDI
• Intapp (INTA) Q4 2025: Cloud ARR Jumps 29% as AI and Enterprise Push Drive Expansion
  August 13, 2025 · INTA
• CAVA (CAVA) Q2 2025: New Restaurant Cohorts Drive 40%+ Cash Returns, Cementing Expansion Model
  August 13, 2025 · CAVA
• CVV Q2 2025: Orders Drop 57% as Tariff Uncertainty and Funding Cuts Pressure Backlog
  August 13, 2025 · CVV
• Journey Medical (DERM) Q2 2025: Amrosi Drives $2.8M Launch, Lifts Gross Margin to 67%
  August 13, 2025 · DERM
• Grail (GRAL) Q2 2025: Gallery Repeat Testing Climbs to 25%, Powering Evidence-Driven Expansion
  August 13, 2025 · GRAL
• Voyager Technologies (VYGR) Q2 2025: Defense and National Security Revenue Surges 85%, Reinforcing Platform Leverage
  August 13, 2025 · VYGR
• Inovio (INO) Q2 2025: Operating Expenses Drop 31% as 3107 Nears BLA Submission
  August 13, 2025 · INO
• PublicSq. (PSQH) Q2 2025: FinTech Revenue Jumps 80% as Strategic Pivot Accelerates
  August 13, 2025 · PSQH
• Zevra (ZVRA) Q2 2025: MyPlypha Drives 26% Sequential Revenue Growth, Expands Rare Disease Reach
  August 13, 2025 · ZVRA
• Pixelworks (PXLW) Q2 2025: Operating Expenses Down $3M, Cost Structure Reset Drives Near-Term Flexibility
  August 13, 2025 · PXLW
• Lumentum (LITE) Q4 2025: Cloud & Networking Jumps 67% as AI Demand Drives Supply Constraints
  August 13, 2025 · LITE
• Rigetti (RGTI) Q2 2025: Chiplet Milestone Slashes Error Rate 2x, Pushing Toward Quantum Advantage
  August 12, 2025 · RGTI
• Theravance Biopharma (TBPH) Q2 2025: UPLRI Sales Jump 22% as Cypress Nears Key Catalyst
  August 12, 2025 · TBPH
• Stoke Therapeutics (STOK) Q2 2025: 36-Month Cognition Gains Anchor Zareva-Nursen’s Disease-Modifying Case
  August 12, 2025 · STOK
• NeuroPace (NPCE) Q2 2025: Gross Margin Rises to 77.1% as RNS Platform Momentum Accelerates
  August 12, 2025 · NPCE
• Pulse Biosciences (PLSE) Q2 2025: R&D Spend to Rise with Two IDE Trials and Commercial Launch
  August 12, 2025 · PLSE
• Webtoon (WBTN) Q2 2025: Disney Deal Unlocks 100+ IP Titles, Fuels Platform Monetization Ambitions
  August 12, 2025 · WBTN
• Fathom Holdings (FTHM) Q2 2025: Elevate Agents Drive 4x Gross Profit, Anchoring Platform Margin Expansion
  August 12, 2025 · FTHM
• KinderCare (KLC) Q2 2025: Net Income Jumps 35% as B2B and Subsidy Tailwinds Offset Enrollment Dip
  August 12, 2025 · KLC
• Fractal Health (GUTS) Q2 2025: $23M Capital Raise Extends Runway Through Critical Revita Data Milestones
  August 12, 2025 · GUTS
• Abcide (ABSI) Q2 2025: $64M Capital Raise Extends Runway, Puts ABS-201 on Accelerated Path
  August 12, 2025 · ABSI
• Sparrow Therapeutics (SPRO) Q2 2025: PIVOT-PO Early Stop Triggers $13M R&D Savings, Extends Cash Runway to 2028
  August 12, 2025 · SPRO
• Lineage Cell Therapeutics (LCTX) Q2 2025: $14.8M Non-Cash Impairment Spotlights Pipeline Refocus and Platform Leverage
  August 12, 2025 · LCTX
• Surf Air Mobility (SRFM) Q2 2025: Completion Factor Hits 95%, Unlocking Operational and Software Leverage
  August 12, 2025 · SRFM
• IZEA (IZEA) Q2 2025: Operating Expenses Drop 41%, Unlocking First-Ever Profitability
  August 12, 2025 · CURR
• Mineralis (MLYS) Q2 2025: $324.9M Cash Position Extends Runway Beyond Pivotal Lorundrastat Milestones
  August 12, 2025 · MLYS
• IZEA (IZEA) Q2 2025: Cost Cuts Slash OpEx 41%, Unlocking First-Ever Operating Profit
  August 12, 2025 · IZEA
• SoundThinking (SSTI) Q2 2025: $37M Pipeline Fuels Post-Chicago Growth Strategy
  August 12, 2025 · SSTI
• GCT Semiconductor (GCTS) Q2 2025: 5G Chipset ASP Set to Quadruple Legacy Levels as Production Ramps
  August 12, 2025 · GCTS
• Trisalis Life Sciences (TLSI) Q2 2025: TriNavFlex Launch Fuels 52% Revenue Surge and Expands Clinical Reach
  August 12, 2025 · TLSI
• Spectral AI (MDAI) Q2 2025: $10.5M Cash Bolsters FDA Commercialization Runway
  August 12, 2025 · MDAI
• Lightbridge (LTBR) Q2 2025: Cash Position Surges to $98M, Accelerating Advanced Fuel Roadmap
  August 12, 2025 · LTBR
• PennantPark (PNNT) Q3 2025: $55M Spillover Income Bridges Dividend Amid Equity Rotation
  August 12, 2025 · PNNT
• Westport Fuel Systems (WPRT) Q2 2025: $62.5M Light Duty Divestiture Reshapes Strategic Focus
  August 12, 2025 · WPRT
• IFS (IFS) Q2 2025: ROE Tops 20% as Wealth Management, Insurance Drive Diversification
  August 12, 2025 · IFS